Cargando…

‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial

AIM: To evaluate the efficacy and safety of ticagrelor monotherapy beyond 1 month and up to 24 months vs. standard 12-month dual antiplatelet therapy (DAPT) with aspirin and ticagrelor followed by aspirin monotherapy among ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gamal, Amr S, Hara, Hironori, Tomaniak, Mariusz, Lunardi, Mattia, Gao, Chao, Ono, Masafumi, Kawashima, Hideyuki, Jüni, Peter, Vranckx, Pascal, Windecker, Stephan, Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Serruys, Patrick W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Scientific Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483765/ https://www.ncbi.nlm.nih.gov/pubmed/34212187 http://dx.doi.org/10.1093/ehjacc/zuab033

Ejemplares similares

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
por: Gao, Chao, et al.
Publicado: (2020)

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
por: Gragnano, Felice, et al.
Publicado: (2022)

Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial
por: Vranckx, Pascal, et al.
Publicado: (2021)

Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond
por: Wang, Rutao, et al.
Publicado: (2021)

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
por: Ono, Masafumi, et al.
Publicado: (2022)

The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial
por: Ono, Masafumi, et al.
Publicado: (2020)

The Impact of Renal Impairment on Long-Term Safety and Effectiveness of Drug-Eluting Stents
por: Stefanini, Giulio G., et al.
Publicado: (2014)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI
por: Bastiany, Alexandra, et al.
Publicado: (2018)

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
por: Birkeland, Kade, et al.
Publicado: (2010)

Ticagrelor: The first approved reversible oral antiplatelet agent
por: Goel, Divya
Publicado: (2013)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
por: Wang, Zhe, et al.
Publicado: (2020)

Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events
por: Kawashima, Hideyuki, et al.
Publicado: (2020)

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor
por: Marczewski, Margaret M, et al.
Publicado: (2010)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
por: Petousis, Stylianos, et al.
Publicado: (2022)

Promoting vascular healing using nanofibrous ticagrelor-eluting stents
por: Lee, Cheng-Hung, et al.
Publicado: (2018)

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
por: Alexopoulos, Dimitrios, et al.
Publicado: (2013)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Dual antiplatelet agents and Rivaroxaban for massive intracoronary thrombus in STEMI
por: Jamal, Nasiruddin, et al.
Publicado: (2015)

Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring
por: Procyk, Grzegorz, et al.
Publicado: (2022)

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
por: Sabaté, Manel, et al.
Publicado: (2016)

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)
por: Leonardi, Sergio, et al.
Publicado: (2019)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
por: Choi, Woong Gil, et al.
Publicado: (2021)

The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective
por: Kawashima, H., et al.
Publicado: (2020)

Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial
por: Li, Pan, et al.
Publicado: (2016)

Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
por: Campos, Carlos M., et al.
Publicado: (2013)

Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor
por: Davis, Estella M, et al.
Publicado: (2013)

Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?
por: Suryanarayana Sharma, Pattanagere Manjunatha, et al.
Publicado: (2015)

Long-term monotherapy with ticagrelor after coronary stenting: the GLOBAL LEADERS study
por: Greco, Antonio, et al.
Publicado: (2020)

Severe complication of early cessation of therapy with ticagrelor after drug-eluting stent implantation
por: Ahmed, Natasha, et al.
Publicado: (2021)

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016)

Perioperative management of antiplatelet therapy in patients with drug-eluting stents
por: Dimitrova, G, et al.
Publicado: (2012)

Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial
por: Smits, Pieter C., et al.
Publicado: (2021)

Acute and chronic exercise training in patients with Class II pulmonary hypertension: effects on haemodynamics and symptoms
por: Lunardi, Mattia, et al.
Publicado: (2022)

Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity
por: Son, Gi-Ho, et al.
Publicado: (2019)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Walking the Line with Ticagrelor: Meta-Analysis Comparing the Safety and Efficacy of Ticagrelor Monotherapy after a Short Course of Ticagrelor-Based Dual Antiplatelet Therapy versus Standard Therapy in Complex Percutaneous Coronary Intervention
por: Condello, Francesco, et al.
Publicado: (2021)

Effect of ticagrelor on the serum level of hs-CRP, ESM-1 and short-term prognosis of patients with acute STEMI
por: Wei, Peng, et al.
Publicado: (2017)

Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
por: Li, Yike, et al.
Publicado: (2023)

Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
por: Kim, Byung Gyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1kbsbais543lhgmuau4trr7gmg